EUVIMEDEUVIMED entdecken
Crossref

hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3–Erk1/2 Signaling Pathway

Sehyeon Han, Soyoung Jang, Seoung-Woo Lee, Hee-Yeon Kim, Wansoo Kim, Hyeon-Gyeom Kim, Jin-Kyu Park, Jee Eun Han, Zae Young Ryoo, Ethan Seah, Choonok Kim, Jiyeon Lee und 2 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.17097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Sehyeon Han und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Companion Animal Industry, College of Health Science, Honam University, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Apoptosis, Cell Proliferation, Disease Progression, MAP Kinase Signaling System.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisCell ProliferationDisease ProgressionMAP Kinase Signaling SystemProstatic NeoplasmsHumansMaleCell Line, TumorCell MovementGene Expression Regulation, NeoplasticTranscription FactorsNeoplasm ProteinsMelanoma-Specific Antigens

Stichwörter der Autor:innen

Prostate cancerRAS/MAPK/Erk1/2 signalingephrin A3human melanoma-associated antigen A2

Substanzen

Transcription FactorsEAF2 protein, humanMageA2 protein, humanNeoplasm ProteinsMelanoma-Specific Antigens

Autor:innen und Institutionen

  • Department of Companion Animal Industry, College of Health Science, Honam University, Gwangju, Republic of Korea.
  • School of Life Science, BK21 FOUR KNU Creative Bioresearch Group, Kyungpook National University, Daegu, Republic of Korea.
  • Core Protein Resources Center, DGIST, Daegu, Republic of Korea.
  • Division of Biomedical Technology, DGIST, Daegu, Republic of Korea.
  • College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea.
  • J INTS BIO Inc., Seoul, Republic of Korea.

Zitieren

APA

Han, S., Jang, S., Lee, S. W., Kim, H. Y., Kim, W., Kim, H. G., Park, J. K., Han, J. E., Ryoo, Z. Y., Seah, E., Kim, C., Lee, J., Park, S., & Choi, S. K. (2024). hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3–Erk1/2 Signaling Pathway. Anticancer Research. https://doi.org/10.21873/anticanres.17097

Vancouver

Han S, Jang S, Lee SW, Kim HY, Kim W, Kim HG, et al. hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3–Erk1/2 Signaling Pathway. Anticancer Research. 2024. doi:10.21873/anticanres.17097

BibTeX
@article{Han2024,
  author = {Han, Sehyeon and Jang, Soyoung and Lee, Seoung-Woo and Kim, Hee-Yeon and Kim, Wansoo and Kim, Hyeon-Gyeom and Park, Jin-Kyu and Han, Jee Eun and Ryoo, Zae Young and Seah, Ethan and Kim, Choonok and Lee, Jiyeon and Park, Song and Choi, Seong-Kyoon},
  title = {hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3–Erk1/2 Signaling Pathway},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17097}
}
Kostenlos starten →